GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (NYSE:COR) » Definitions » Cyclically Adjusted PS Ratio

COR (Cencora) Cyclically Adjusted PS Ratio : 0.25 (As of May. 09, 2025)


View and export this data going back to 1995. Start your Free Trial

What is Cencora Cyclically Adjusted PS Ratio?

As of today (2025-05-09), Cencora's current share price is $283.00. Cencora's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $1,150.25. Cencora's Cyclically Adjusted PS Ratio for today is 0.25.

The historical rank and industry rank for Cencora's Cyclically Adjusted PS Ratio or its related term are showing as below:

COR' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.14   Med: 0.19   Max: 0.37
Current: 0.25

During the past years, Cencora's highest Cyclically Adjusted PS Ratio was 0.37. The lowest was 0.14. And the median was 0.19.

COR's Cyclically Adjusted PS Ratio is ranked better than
60% of 75 companies
in the Medical Distribution industry
Industry Median: 0.43 vs COR: 0.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cencora's adjusted revenue per share data for the three months ended in Mar. 2025 was $386.755. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $1,150.25 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cencora Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Cencora's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Cyclically Adjusted PS Ratio Chart

Cencora Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.16 0.15 0.18 0.21

Cencora Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.21 0.21 0.20 0.24

Competitive Comparison of Cencora's Cyclically Adjusted PS Ratio

For the Medical Distribution subindustry, Cencora's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cencora's Cyclically Adjusted PS Ratio falls into.


;
;

Cencora Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cencora's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=283.00/1150.25
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Cencora's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=386.755/134.9266*134.9266
=386.755

Current CPI (Mar. 2025) = 134.9266.

Cencora Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 142.500 100.684 190.964
201509 167.252 100.392 224.787
201512 161.915 99.792 218.921
201603 158.343 100.470 212.647
201606 164.063 101.688 217.690
201609 165.540 101.861 219.277
201612 171.950 101.863 227.764
201703 167.920 102.862 220.264
201706 174.456 103.349 227.760
201709 176.762 104.136 229.027
201712 183.253 104.011 237.722
201803 184.585 105.290 236.542
201806 195.426 106.317 248.015
201809 199.110 106.507 252.240
201812 212.145 105.998 270.043
201903 203.797 107.251 256.387
201906 214.241 108.070 267.484
201909 213.353 108.329 265.736
201912 230.655 108.420 287.045
202003 229.002 108.902 283.729
202006 220.716 108.767 273.800
202009 241.300 109.815 296.479
202012 253.947 109.897 311.785
202103 237.099 111.754 286.261
202106 255.637 114.631 300.897
202109 279.440 115.734 325.780
202112 282.376 117.630 323.899
202203 272.273 121.301 302.857
202206 283.674 125.017 306.160
202209 291.387 125.227 313.958
202212 304.598 125.222 328.205
202303 310.675 127.348 329.164
202306 327.570 128.729 343.342
202309 338.886 129.860 352.109
202312 357.976 129.419 373.209
202403 340.070 131.776 348.200
202406 371.120 132.554 377.763
202409 399.120 133.029 404.814
202412 417.480 133.157 423.028
202503 386.755 134.927 386.755

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cencora  (NYSE:COR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cencora Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Cencora's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cencora Business Description

Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Executives
Steven H Collis officer: President & CEO 1300 MORRIS DRIVE, SUITE 100, CHESTERBROOK PA 19087
Elizabeth S Campbell officer: Executive Vice President 1 WEST FIRST AVENUE, CONSHOHOCKEN PA 19428
Robert P. Mauch officer: Executive Vice President 1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Lazarus Krikorian officer: Senior Vice President 1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Silvana Battaglia officer: Executive Vice President 227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Walgreens Boots Alliance, Inc. 10 percent owner 108 WILMOT ROAD, DEERFIELD IL 60015
Gina Clark officer: Executive Vice President 1300 MORRIS DRIVE, CHESTERBROOK PA 19087
Dermot Mark Durcan director
Leslie E Donato officer: EVP & Chief Strategy Officer 227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Werner Baumann director 1 WEST FIRST AVENUE, CONSHOHOCKEN PA 19428
Lauren M Tyler director C/O ALLEGHANY CORPORATION, 1411 BROADWAY, 34TH FLOOR, NEW YORK NY 10018
Redonda Miller director 303 WYMAN STREET, SUITE 300, WALTHAM MA 02451
Lorence H. Kim director C/O SERES HEALTH, INC., 161 FIRST STREET, CAMBRIDGE MA 02472
Walgreens Boots Alliance Holdings Llc 10 percent owner 108 WILMOT ROAD, DEERFIELD IL 60015
Lon R Greenberg director 460 NORTH GULPH ROAD, KING OF PRUSSIA PA 19406